Wednesday, April 10, 2019

Ovarian cancer patients undertested for mutations that could guide clinical care

Fewer than a quarter of breast cancer patients and a third of ovarian cancer patients diagnosed between 2013 and 2014 in two states underwent genetic testing for cancer-associated mutations, according to a new study.

from Top Health News -- ScienceDaily http://bit.ly/2I6Sphy

No comments:

Post a Comment

Vitamin D drug may help crack pancreatic cancer’s protective shield

A vitamin D analog may help break down pancreatic cancer’s protective defenses, potentially making tumors more vulnerable to chemotherapy an...